Goldman Sachs analyst David Roman maintained a Buy rating on Insulet today and set a price target of $277.00. Roman covers the Healthcare sector, f......

Goldman Sachs analyst David Roman maintained a Buy rating on Insulet today and set a price target of $277.00. Roman covers the Healthcare sector, f......

The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index (SPX), rose 2.63% in today’s pre-market trading after President Donald Trump announ......

The SPDR S&P 500 ETF Trust ($SPY) gained 0.47% today, April 6, driven by optimism regarding a potential ceasefire deal between the U.S. and Iran an......

The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index (SPX), rose a modest 0.06% in today’s pre-market trading, as investors awaited Tues......

In a report released on April 2, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Insulet, with a price target of $380.00. The compa......

The Vanguard S&P 500 ETF ($VOO), which tracks the S&P 500 Index (SPX), closed 1.50% higher in Thursday’s trading following news that Iran and Oman ......

The SPDR S&P 500 ETF Trust ($SPY) gained 0.09% today, April 2, marking a continued rally driven primarily by hopes of de-escalation in the Iran con......

Escalating tensions in the Middle East, a spike in crude prices, and signs of fatigue in the U.S. labor market are fueling fresh analyst chatter ab......

A combination of the conflict in the Middle East, soaring oil prices, and a weaker U.S. job market has led to rising warnings from analysts about t......